Details of the Drug
General Information of Drug (ID: DMYI87T)
Drug Name |
N-ethylhistamine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
479408-49-6; 2-(1-ethyl-1h-imidazol-4-yl)ethanamine; 1-ETHYL-1H-IMIDAZOLE-4-ETHANAMINE; 2-(1-Ethyl-1H-imidazol-4-yl)ethan-1-amine; N-ethylhistamine; 2-(1-Ethyl-1H-imidazol-4-yl)ethylamine; CHEMBL46296; SCHEMBL589342; GTPL1271; CTK4J0489; DTXSID90658170; LIXGKSRWGHVUHT-UHFFFAOYSA-N; ZINC29412524; 2-(1-ethylimidazol-4-yl)ethanamine; AKOS006337816
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure |
![]() |
||||||||||||||||||||||
3D MOL is unavailable | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 139.2 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -0.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References